DBV Technologies
DBVT· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +520.4% in FY2025
Daniel Tassé is the CEO of DBV Technologies and was paid $3.4M in FY2025 (Dec), up 128%.
Pay$100 in the stock at the end of FY23 → $201
Executives3
See all- 1Daniel TasséChief Executive Officer and DirectorFY2025
- 2Pharis MohideenChief Medical OfficerFY2025
- 3Virginie BoucinhaChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allDBV Technologies paid its 3 named executives $6.1M in total in FY2025 (Dec). CEO Daniel Tassé was paid $3.4M of that.
| Name | |||
|---|---|---|---|
| Daniel TasséChief Executive Officer and Director | Not disclosed | ||
| Pharis MohideenChief Medical Officer | Not disclosed | ||
| Virginie BoucinhaChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for DBV Technologies. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board6
See all- Daniel B. SolandDirector · 9 yr on the boardIndependentCompensation—Paid as an executive
- Michael J. GollerDirector · 9 yr on the boardNot independentNominating and Governance (Chair)—Paid as an executive
- Maïlys FerrèreDirector · 8 yr on the boardNot independentNominating and Governance—Paid as an executive
- Adora NduDirector · 3 yr on the boardIndependentAudit—Paid as an executive
- Ravi M. RaoDirector · 3 yr on the boardIndependentNominating and Governance—Paid as an executive
- Timothy E. MorrisDirector · 3 yr on the boardIndependentAudit (Chair)—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | May 11, 2026 | FY2025 |
| Annual report | 10-K | Mar 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | May 15, 2025 | FY2024 |
| Annual report | 10-K | Apr 11, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 7, 2024 | FY2023 |
